Tapewire

Nasdaq · USD

CPIX

CUMBERLAND PHARMACEUTICALS INC

Export transactions ↓
Tapewire entity
6757
SEC CIK
0001087294
Parsed reports
362

Last 12 months

Inside the activity.

0 purchase rows · 0 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202500
Jan 202600
Feb 202600
Mar 202600
Apr 202600
May 202600
Jun 202600
Jul 202600
Aug 202600
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
August 03, 2022 Filed Aug 19, 2022 21:31 UTC
Jones JamesDirector
PurchaseCommon Stock 20 $2.45 $49.00
Disclosure

SEC source: 0001209191-22-046898 · doc4.xml · nonDerivative · entry 20

Jones James · CIK 0001490829 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 22,949

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
August 03, 2022 Filed Aug 19, 2022 21:30 UTC PurchaseCommon Stock 30 $2.45 $73.50
Disclosure

SEC source: 0001209191-22-046896 · doc4.xml · nonDerivative · entry 20

Galante Joseph C · CIK 0001632384 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 50,268

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
August 03, 2022 Filed Aug 19, 2022 21:28 UTC PurchaseCommon Stock 50 $2.45 $122.50
Disclosure

SEC source: 0001209191-22-046894 · doc4.xml · nonDerivative · entry 20

Krogulski Kenneth · CIK 0001695580 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 192,852

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
August 01, 2022 Filed Aug 19, 2022 21:32 UTC PurchaseCommon Stock 24 $2.34 $56.16
Disclosure

SEC source: 0001209191-22-046900 · doc4.xml · nonDerivative · entry 19

Young Caroline · CIK 0001684087 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,472

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
August 01, 2022 Filed Aug 19, 2022 21:31 UTC
Jones JamesDirector
PurchaseCommon Stock 37 $2.34 $86.58
Disclosure

SEC source: 0001209191-22-046898 · doc4.xml · nonDerivative · entry 19

Jones James · CIK 0001490829 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 22,929

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
August 01, 2022 Filed Aug 19, 2022 21:30 UTC PurchaseCommon Stock 74 $2.34 $173.16
Disclosure

SEC source: 0001209191-22-046896 · doc4.xml · nonDerivative · entry 19

Galante Joseph C · CIK 0001632384 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 50,238

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
August 01, 2022 Filed Aug 19, 2022 21:28 UTC PurchaseCommon Stock 124 $2.34 $290.16
Disclosure

SEC source: 0001209191-22-046894 · doc4.xml · nonDerivative · entry 19

Krogulski Kenneth · CIK 0001695580 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 192,802

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
July 29, 2022 Filed Aug 19, 2022 21:32 UTC PurchaseCommon Stock 24 $2.28 $54.72
Disclosure

SEC source: 0001209191-22-046900 · doc4.xml · nonDerivative · entry 18

Young Caroline · CIK 0001684087 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,448

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
July 29, 2022 Filed Aug 19, 2022 21:31 UTC
Jones JamesDirector
PurchaseCommon Stock 37 $2.28 $84.36
Disclosure

SEC source: 0001209191-22-046898 · doc4.xml · nonDerivative · entry 18

Jones James · CIK 0001490829 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 22,892

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
July 29, 2022 Filed Aug 19, 2022 21:30 UTC PurchaseCommon Stock 74 $2.28 $168.72
Disclosure

SEC source: 0001209191-22-046896 · doc4.xml · nonDerivative · entry 18

Galante Joseph C · CIK 0001632384 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 50,164

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
July 29, 2022 Filed Aug 19, 2022 21:28 UTC PurchaseCommon Stock 124 $2.28 $282.72
Disclosure

SEC source: 0001209191-22-046894 · doc4.xml · nonDerivative · entry 18

Krogulski Kenneth · CIK 0001695580 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 192,678

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
July 28, 2022 Filed Aug 19, 2022 21:32 UTC PurchaseCommon Stock 24 $2.28 $54.72
Disclosure

SEC source: 0001209191-22-046900 · doc4.xml · nonDerivative · entry 17

Young Caroline · CIK 0001684087 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,424

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
July 28, 2022 Filed Aug 19, 2022 21:31 UTC
Jones JamesDirector
PurchaseCommon Stock 37 $2.28 $84.36
Disclosure

SEC source: 0001209191-22-046898 · doc4.xml · nonDerivative · entry 17

Jones James · CIK 0001490829 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 22,855

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
July 28, 2022 Filed Aug 19, 2022 21:30 UTC PurchaseCommon Stock 74 $2.28 $168.72
Disclosure

SEC source: 0001209191-22-046896 · doc4.xml · nonDerivative · entry 17

Galante Joseph C · CIK 0001632384 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 50,090

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
July 28, 2022 Filed Aug 19, 2022 21:28 UTC PurchaseCommon Stock 124 $2.28 $282.72
Disclosure

SEC source: 0001209191-22-046894 · doc4.xml · nonDerivative · entry 17

Krogulski Kenneth · CIK 0001695580 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 192,554

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
July 27, 2022 Filed Aug 19, 2022 21:32 UTC PurchaseCommon Stock 19 $2.36 $44.84
Disclosure

SEC source: 0001209191-22-046900 · doc4.xml · nonDerivative · entry 16

Young Caroline · CIK 0001684087 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,400

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
July 27, 2022 Filed Aug 19, 2022 21:31 UTC
Jones JamesDirector
PurchaseCommon Stock 30 $2.36 $70.80
Disclosure

SEC source: 0001209191-22-046898 · doc4.xml · nonDerivative · entry 16

Jones James · CIK 0001490829 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 22,818

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
July 27, 2022 Filed Aug 19, 2022 21:30 UTC PurchaseCommon Stock 60 $2.36 $141.60
Disclosure

SEC source: 0001209191-22-046896 · doc4.xml · nonDerivative · entry 16

Galante Joseph C · CIK 0001632384 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 50,016

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
July 27, 2022 Filed Aug 19, 2022 21:28 UTC PurchaseCommon Stock 90 $2.36 $212.40
Disclosure

SEC source: 0001209191-22-046894 · doc4.xml · nonDerivative · entry 16

Krogulski Kenneth · CIK 0001695580 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 192,430

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
July 26, 2022 Filed Aug 19, 2022 21:32 UTC PurchaseCommon Stock 24 $2.47 $59.28
Disclosure

SEC source: 0001209191-22-046900 · doc4.xml · nonDerivative · entry 15

Young Caroline · CIK 0001684087 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,381

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
July 26, 2022 Filed Aug 19, 2022 21:31 UTC
Jones JamesDirector
PurchaseCommon Stock 37 $2.47 $91.39
Disclosure

SEC source: 0001209191-22-046898 · doc4.xml · nonDerivative · entry 15

Jones James · CIK 0001490829 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 22,788

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
July 26, 2022 Filed Aug 19, 2022 21:30 UTC PurchaseCommon Stock 74 $2.47 $182.78
Disclosure

SEC source: 0001209191-22-046896 · doc4.xml · nonDerivative · entry 15

Galante Joseph C · CIK 0001632384 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 49,956

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
July 26, 2022 Filed Aug 19, 2022 21:28 UTC PurchaseCommon Stock 124 $2.47 $306.28
Disclosure

SEC source: 0001209191-22-046894 · doc4.xml · nonDerivative · entry 15

Krogulski Kenneth · CIK 0001695580 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 192,340

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
July 25, 2022 Filed Aug 19, 2022 21:32 UTC PurchaseCommon Stock 24 $2.48 $59.52
Disclosure

SEC source: 0001209191-22-046900 · doc4.xml · nonDerivative · entry 14

Young Caroline · CIK 0001684087 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,357

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
July 25, 2022 Filed Aug 19, 2022 21:31 UTC
Jones JamesDirector
PurchaseCommon Stock 37 $2.48 $91.76
Disclosure

SEC source: 0001209191-22-046898 · doc4.xml · nonDerivative · entry 14

Jones James · CIK 0001490829 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 22,751

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
July 25, 2022 Filed Aug 19, 2022 21:30 UTC PurchaseCommon Stock 74 $2.48 $183.52
Disclosure

SEC source: 0001209191-22-046896 · doc4.xml · nonDerivative · entry 14

Galante Joseph C · CIK 0001632384 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 49,882

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
July 25, 2022 Filed Aug 19, 2022 21:28 UTC PurchaseCommon Stock 124 $2.48 $307.52
Disclosure

SEC source: 0001209191-22-046894 · doc4.xml · nonDerivative · entry 14

Krogulski Kenneth · CIK 0001695580 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 192,216

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
July 22, 2022 Filed Aug 19, 2022 21:32 UTC PurchaseCommon Stock 24 $2.53 $60.72
Disclosure

SEC source: 0001209191-22-046900 · doc4.xml · nonDerivative · entry 13

Young Caroline · CIK 0001684087 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,333

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
July 22, 2022 Filed Aug 19, 2022 21:31 UTC
Jones JamesDirector
PurchaseCommon Stock 37 $2.53 $93.61
Disclosure

SEC source: 0001209191-22-046898 · doc4.xml · nonDerivative · entry 13

Jones James · CIK 0001490829 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 22,714

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
July 22, 2022 Filed Aug 19, 2022 21:30 UTC PurchaseCommon Stock 74 $2.53 $187.22
Disclosure

SEC source: 0001209191-22-046896 · doc4.xml · nonDerivative · entry 13

Galante Joseph C · CIK 0001632384 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 49,808

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
July 22, 2022 Filed Aug 19, 2022 21:28 UTC PurchaseCommon Stock 124 $2.53 $313.72
Disclosure

SEC source: 0001209191-22-046894 · doc4.xml · nonDerivative · entry 13

Krogulski Kenneth · CIK 0001695580 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 192,092

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
July 21, 2022 Filed Aug 19, 2022 21:32 UTC PurchaseCommon Stock 24 $2.54 $60.96
Disclosure

SEC source: 0001209191-22-046900 · doc4.xml · nonDerivative · entry 12

Young Caroline · CIK 0001684087 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,309

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
July 21, 2022 Filed Aug 19, 2022 21:31 UTC
Jones JamesDirector
PurchaseCommon Stock 37 $2.54 $93.98
Disclosure

SEC source: 0001209191-22-046898 · doc4.xml · nonDerivative · entry 12

Jones James · CIK 0001490829 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 22,677

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
July 21, 2022 Filed Aug 19, 2022 21:30 UTC PurchaseCommon Stock 74 $2.54 $187.96
Disclosure

SEC source: 0001209191-22-046896 · doc4.xml · nonDerivative · entry 12

Galante Joseph C · CIK 0001632384 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 49,734

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
July 21, 2022 Filed Aug 19, 2022 21:28 UTC PurchaseCommon Stock 124 $2.54 $314.96
Disclosure

SEC source: 0001209191-22-046894 · doc4.xml · nonDerivative · entry 12

Krogulski Kenneth · CIK 0001695580 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 191,968

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
July 20, 2022 Filed Aug 19, 2022 21:32 UTC PurchaseCommon Stock 24 $2.52 $60.48
Disclosure

SEC source: 0001209191-22-046900 · doc4.xml · nonDerivative · entry 11

Young Caroline · CIK 0001684087 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,285

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
July 20, 2022 Filed Aug 19, 2022 21:31 UTC
Jones JamesDirector
PurchaseCommon Stock 37 $2.52 $93.24
Disclosure

SEC source: 0001209191-22-046898 · doc4.xml · nonDerivative · entry 11

Jones James · CIK 0001490829 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 22,640

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
July 20, 2022 Filed Aug 19, 2022 21:30 UTC PurchaseCommon Stock 74 $2.52 $186.48
Disclosure

SEC source: 0001209191-22-046896 · doc4.xml · nonDerivative · entry 11

Galante Joseph C · CIK 0001632384 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 49,660

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
July 20, 2022 Filed Aug 19, 2022 21:28 UTC PurchaseCommon Stock 124 $2.52 $312.48
Disclosure

SEC source: 0001209191-22-046894 · doc4.xml · nonDerivative · entry 11

Krogulski Kenneth · CIK 0001695580 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 191,844

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
July 19, 2022 Filed Aug 19, 2022 21:32 UTC PurchaseCommon Stock 24 $2.47 $59.28
Disclosure

SEC source: 0001209191-22-046900 · doc4.xml · nonDerivative · entry 10

Young Caroline · CIK 0001684087 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,261

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
July 19, 2022 Filed Aug 19, 2022 21:31 UTC
Jones JamesDirector
PurchaseCommon Stock 37 $2.47 $91.39
Disclosure

SEC source: 0001209191-22-046898 · doc4.xml · nonDerivative · entry 10

Jones James · CIK 0001490829 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 22,603

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
July 19, 2022 Filed Aug 19, 2022 21:30 UTC PurchaseCommon Stock 74 $2.47 $182.78
Disclosure

SEC source: 0001209191-22-046896 · doc4.xml · nonDerivative · entry 10

Galante Joseph C · CIK 0001632384 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 49,586

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
July 19, 2022 Filed Aug 19, 2022 21:28 UTC PurchaseCommon Stock 124 $2.47 $306.28
Disclosure

SEC source: 0001209191-22-046894 · doc4.xml · nonDerivative · entry 10

Krogulski Kenneth · CIK 0001695580 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 191,720

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
July 18, 2022 Filed Aug 19, 2022 21:32 UTC PurchaseCommon Stock 24 $2.41 $57.84
Disclosure

SEC source: 0001209191-22-046900 · doc4.xml · nonDerivative · entry 9

Young Caroline · CIK 0001684087 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,237

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
July 18, 2022 Filed Aug 19, 2022 21:31 UTC
Jones JamesDirector
PurchaseCommon Stock 37 $2.41 $89.17
Disclosure

SEC source: 0001209191-22-046898 · doc4.xml · nonDerivative · entry 9

Jones James · CIK 0001490829 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 22,566

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
July 18, 2022 Filed Aug 19, 2022 21:30 UTC PurchaseCommon Stock 74 $2.41 $178.34
Disclosure

SEC source: 0001209191-22-046896 · doc4.xml · nonDerivative · entry 9

Galante Joseph C · CIK 0001632384 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 49,512

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
July 18, 2022 Filed Aug 19, 2022 21:28 UTC PurchaseCommon Stock 124 $2.41 $298.84
Disclosure

SEC source: 0001209191-22-046894 · doc4.xml · nonDerivative · entry 9

Krogulski Kenneth · CIK 0001695580 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 191,596

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
July 15, 2022 Filed Aug 19, 2022 21:32 UTC PurchaseCommon Stock 27 $2.23 $60.21
Disclosure

SEC source: 0001209191-22-046900 · doc4.xml · nonDerivative · entry 8

Young Caroline · CIK 0001684087 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,213

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
July 15, 2022 Filed Aug 19, 2022 21:31 UTC
Jones JamesDirector
PurchaseCommon Stock 43 $2.23 $95.89
Disclosure

SEC source: 0001209191-22-046898 · doc4.xml · nonDerivative · entry 8

Jones James · CIK 0001490829 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 22,529

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
July 15, 2022 Filed Aug 19, 2022 21:30 UTC PurchaseCommon Stock 86 $2.23 $191.78
Disclosure

SEC source: 0001209191-22-046896 · doc4.xml · nonDerivative · entry 8

Galante Joseph C · CIK 0001632384 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 49,438

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.